Psagot Investment House logo

Psagot Investment House

Asia, Tel Aviv, Israel, Tel Aviv

Description

The Psagot Investment House is an Israeli investment firm and the country's largest pension fund manager.

Investor Profile

Psagot Investment House has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • Israel (50%)
  • United States (50%)

Industry Focus

  • Therapeutics
  • Biotechnology
  • Manufacturing
  • Pharmaceutical
  • Health Care
  • Health Diagnostics
  • Medical Device
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Psagot Investment House frequently co-invest with?

Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 1
Rosalind Capital Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
AG
Asia, Tel Aviv, Israel, Tel Aviv-yafo
Co-Investments: 1
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1
SternAegis
North America, New York, United States, New York
Co-Investments: 1
UO
North America, Illinois, United States, Chicago
Co-Investments: 1
More Investment House
Asia, Tel Aviv, Israel, Ramat Gan
Co-Investments: 1
Phoenix Financial
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1

What are some of recent deals done by Psagot Investment House?

DarioHealth

New York, New York, United States

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Health CareHealth DiagnosticsMedical DeviceSoftwareTherapeutics
Post Ipo EquityJul 21, 2020
Amount Raised: $28,600,000
Protalix BioTherapeutics

Carmiel, HaZafon, Israel

Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Post Ipo EquityMar 12, 2020
Amount Raised: $43,700,000